Inventor

LEVIN JEREMY I

US42 patents

⚠️ This page may combine multiple inventors who share the name “LEVIN JEREMY I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEVIN JEREMY I

AMERICAN CYANAMID CO

Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors

Renin inhibitors

Acetylenic sulfonamide thiol tace inhibitors

Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors

Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors

Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6-substituted quinazolinones

Benzoylaminoquinazolinones

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking agents

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Angiotensin II receptor blocking 2,3,6-substituted quinazolinones

2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones

5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders

Angiotensin II receptor blocking 2,3,6-substituted quinazolinones

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

Method of treating or inhibiting neutropenia

WYETH CORP

Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors

Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors

Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors

Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors

Method for preparing hydroxamic acids

Method for the treatment of polycystic kidney disease

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors

Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase

Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase

LEVIN JEREMY I

Expedient route to aryl propenoic esters